key: cord-0862180-qkp0kqyg
authors: Heerfordt, Ida M.
title: Decreased public awareness of skin cancer during the coronavirus pandemic
date: 2021-05-13
journal: Int J Dermatol
DOI: 10.1111/ijd.15659
sha: 5fbd59636a5005f0161b9ce5c854f8947f5f0bc9
doc_id: 862180
cord_uid: qkp0kqyg

nan

decline is yet unknown and is likely to be multifactorial. It may be due to longer processing times for non-coronavirus concerns at general practitioners and hospitals. Maybe fewer people are consulting the healthcare system with skin cancer suspicion, either because something is stopping them or because they do not have skin cancer in focus.

This study investigated whether there has been a decrease in public awareness of skin cancer during the coronavirus pandemic in 2020 compared to 2019. Additionally, the study examined if there has been a development through the pandemic. Therefore, public interest was investigated in the early phase and the latter part of 2020.

Internet traffic can be a proxy for public awareness. 2 Worldwide people search for health-related information online, which makes web search queries on Google Trends a valuable data source on health tendencies. 3 The public awareness of skin cancer was investigated using Google Trends. Google Trends provides information on how many hits different terms had in a given week on Google.

The highest interest on a search query is quantified as 100 relative search volume (RSV), decreasing to 0 RSV representing no interest (www.support.google.com/trends). Worldwide public query data for the following terms "skin cancer," "melanoma," "basal cell carcinoma," and "squamous cell carcinoma" between The awareness of "skin cancer," "melanoma," "basal cell carcinoma," and "squamous cell carcinoma" was significantly reduced (P < 0.001) during the first 5 months of the pandemic compared to 2019 with a mean difference in RSV between À9

and À17.

In the latter part of 2020, smaller reductions in public awareness were found with a mean difference in RSV between À3 and À12. For "skin cancer," "melanoma," and "basal cell carcinoma," the reduction was statistically significant (P ≤ 0.002). For squamous cell carcinoma, the reduction was statistically insignificant (P = 0.092). Table 1 presents all results.

It is very unlikely that there has been a real decline in skin cancer incidence in 2020. 1 The declining number of patients diagnosed with skin cancer during the coronavirus pandemic is most likely due to missed diagnoses. As a positive prognosis is highly dependent on a diagnosis being made at an early stage of the disease, it is important to re-establish timely skin cancer diagnosis. 4, 5 To be able to do this, it is important to know the reasons for the delay. This study suggests decreased worldwide public awareness of skin cancer as part of the multifactorial cause. Awareness was particularly reduced in the first months of the pandemic and was still reduced in the latter part of 2020.

Google Trends can be used to follow the interest in skin cancer during the continued coronavirus pandemic.

No ethical approval from the Committee on Health Research

Ethics was needed. The data used in this study were freely available information on trends.google.com and were completely anonymized. March-July 2020 compared to 2019 August-December 2020 compared to 2019

Skin cancer À15 (P < 0.001) À7 (P < 0.001) Melanoma À16 (P < 0.001) À12 (P < 0.001) Basal cell carcinoma À17 (P < 0.001) À11 (P = 0.002) Squamous cell carcinoma À9 (P < 0.001) À3 (P = 0.092) ª 2021 the International Society of Dermatology International Journal of Dermatology 2021

Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic

Disease monitoring and health campaign evaluation using Google search activities for HIV and AIDS, stroke, colorectal cancer, and marijuana use in Canada: a retrospective observational study

Has there been an increased interest in smoking cessation during the first months of the COVID-19 pandemic? A Google Trends study

Melanoma survival in the United States, 1992 to

Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death